Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2014

Aug 21, 2014

30339_dirs_2014-08-21_21d4f950-54b6-461f-90ef-9725c298481b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-08-19

Reporting Person: ANDERSON MICHAEL A (Vice President & Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-19 Common Stock S 180.0000 $43.4101 Disposed 76932.5040 Direct
2014-08-19 Common Stock S 600.0000 $43.4200 Disposed 76332.5040 Direct
2014-08-19 Common Stock S 1920.0000 $43.4126 Disposed 74412.5040 Direct
2014-08-19 Common Stock S 2100.0000 $43.4138 Disposed 72312.5040 Direct
2014-08-19 Common Stock S 5000.0000 $43.4108 Disposed 67312.5040 Direct
2014-08-20 Common Stock M 3400.0000 $12.7650 Acquired 70712.5040 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-08-20 Stock Option (Right to Buy) $12.7650 M 3400.0000 Disposed 2015-03-09 Common Stock (3400.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 902.9538 Indirect
Common Stock 7256.5400 Indirect